Microbial levan potentiates hepatic retention and antitumor activity of a PEGylated benzimidazole–curcumin nanocomplex through TLR2–FXR/FGF15-associated immunometabolic remodeling in experimental liver cancer
Heba Shawky, Noha E. Ibrahim, Mai N. Amer, Aisha A. K. Al-Ashmawy, Olfat A. Hammam, Dalia B. Fayed, Amany S. Maghraby · 2026
Read Microbial levan potentiates hepatic retention and antitumor activity of a PEGylated benzimidazole–curcumin nanocomplex through TLR2–FXR/FGF15-associated immunometabolic remodeling in experimental liver cancer by Heba Shawky, Noha E. Ibrahim, Mai N. Amer, Aisha A. K. Al-Ashmawy, Olfat A. Hammam, Dalia B. Fayed, Amany S. Maghraby (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13462577.txt.
Description
Despite major advances in nanomedicine, therapeutic efficacy remains constrained by unfavorable host responses that influence nanotherapeutic retention, biodistribution, and activity. Biological strategies capable of enhancing nanomedicine performance through modulation of host-response pathways, rather than additional nanoparticle engineering, remain largely unexplored.
Catalog record
| CREATOR | Heba Shawky, Noha E. Ibrahim, Mai N. Amer, Aisha A. K. Al-Ashmawy, Olfat A. Hammam, Dalia B. Fayed, Amany S. Maghraby |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 94 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |